Order byBest matchMost fresh
100 days into the job, FDA head talks to CNN about agency goals— and Coke’s switch to sugar
Marty Makary says the FDA will plow ahead with big plans on ultra processed foods, dietary guidelines, and expedited drug and devices reviews.
FDA chief talks staffing, abortion drug and tobacco
The FDA is still on track to meet its user fee targets despite a higher-than-normal vacancy rate among scientific reviewers.
Lawmakers press FDA to target knockoff weight-loss drug
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks.
Pickles Recall Update As FDA Issues Risk Warning
The recall has been given a Class II classification, indicating there is a significant level of risk posed to consumers in Minnesota.
FDA Upgrades Recall on 160,000+ Bottles of Thyroid Medication
The recall of more than 160,000 bottles of levothyroxine sodium, which went into effect June 20, was upgraded to a Class II recall on July 23. Class II recalls occur when use of the drug poses a moderate public health risk, according to the FDA.
Explore more
FDA Head To ‘Listen To Concerns’ Regarding Coerced Use Of Abortion Pill Widely Available Online
Commissioner Marty Makary said in an interview with Politico’s Dasha Burns that the FDA will “look at the data” surrounding the abortion drug, mifepristone, including concerns” that pregnant women are suffering coercion to take the pill “outside the prescribing authority of a physician.
Nationwide Ritz Cracker Recall Update as FDA Issues Risk Warning
Mondelēz Global announced a recall for various sizes of Ritz peanut butter cracker sandwiches over possible undeclared allergens.
FDA commissioner: No ‘preconceived plans’ on policy changes for abortion drug
Food and Drug Administration Commissioner Marty Makary said he has “no preconceived plans” to change the policies on mifepristone, an abortion pill that ends pregnancy before 10 weeks, in an interview with POLITICO.
Prescription fluoride faces FDA scrutiny despite widespread support from providers and the public
The US Food and Drug Administration appears poised to continue with a plan to ban prescription fluoride supplements at a time when many experts say that access to the products has become especially important.
FDA closes investigation into deadly listeria outbreak
The Food and Drug Administration has closed an investigation into a listeria outbreak that killed one person and sickened 10 in several western states, health officials announced Thursday.
FDA Recalls Single-Serve Coffee Pods Over Potentially Toxic Brewing Risk
FDA Recalls Single-Serve Coffee Pods Over Potentially Toxic Brewing Risk originally appeared on Men's Fitness. Keurig users, beware. A popular coffee brand has issued a voluntary recall of its single-serve coffee pods.
Feedback